Molecular Detection and Diagnostics Core

分子检测和诊断核心

基本信息

  • 批准号:
    10664051
  • 负责人:
  • 金额:
    $ 17.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-10 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT (Molecular Detection and Diagnostics Core) The Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases Phase 2 application aims to further develop and strengthen the clinical and translational research infrastructure at Tulane University and to continuously expand and support a critical mass of investigators with expertise in clinical and translational research in cardiometabolic diseases. The newly proposed Molecular Detection and Diagnostics Core (MDDC) will support the Research Project Leaders (RPLs), Pilot Project Leaders (PPLs), other COBRE investigators and collaborators at Tulane University by providing cutting-edge instruments, innovative technologies and methodologies, and expertise in multidisciplinary research including biochemistry, biomedical engineering, analytical chemistry, proteomics, nanotechnology, and mass spectrometry (MS) to advance their clinical and translational research in the etiology, prevention, diagnosis, and treatment of cardiometabolic disease. The MDDC will develop and adapt integrated nanotechnology-based strategies and other innovative technologies to identify novel biomarkers for early disease detection, prognostic evaluation, and the real-time monitoring of treatment responses as well as to understand the molecular mechanisms of cardiometabolic disease. The MDDC seeks to catalyze research that spans the analytical chemistry-biology interface, empowering investigators to identify and solve important interdisciplinary research questions in the clinical and translational sciences of cardiometabolic disease. Based on our team's expertise, the MDDC will provide COBRE investigators with training and services in state-of-the-art analytical technologies such as MS and microarray-based proteomics and organ-on-a-chip, among others, for the analysis of complex proteomes of tissue and biofluid samples. The MDDC will also identify appropriate existing analytical methods as well as adapt newly developed methods, often not available in the form of mature technologies. The MDDC will be housed within the Tulane University Center for Cellular and Molecular Diagnostics, which has been well established for infectious and chronic disease research. During the COBRE Phase 2, the MDDC will provide cutting-edge instruments and methodological support for RPLs of Projects 2 and 3 to conduct their individual research projects. In addition, the MDDC will provide expert consultation and state-of-the-art technologies for RPLs of Projects 1 and 4 to develop R01 applications to further investigate molecular mechanism of APOL1 on chronic kidney disease progression and potassium intake on blood pressure reduction. The proposed MDDC will enhance the interactions and collaborations among COBRE, non-COBRE and external investigators involved in molecular studies of cardiometabolic disease. Since the MDDC is a critical component of the COBRE program, our long-term goal is to grow MDDC into a sustainable resource that serves all phases of translational research, from basic science to clinical science to population science at Tulane University by providing a broad range of state-of-the-art cellular and molecular analytical services.
项目总结/摘要(分子检测和诊断核心) Tulane COBRE用于心脏代谢疾病的临床和转化研究2期应用 旨在进一步发展和加强杜兰大学的临床和转化研究基础设施 并不断扩大和支持具有临床和翻译专业知识的研究者的临界质量 心脏代谢疾病的研究。新提出的分子检测和诊断核心(MDDC) 将支持研究项目负责人(RPL)、试点项目负责人(PPL)、其他COBRE研究人员, 通过提供尖端仪器,创新技术和 方法,和多学科研究的专业知识,包括生物化学,生物医学工程, 分析化学,蛋白质组学,纳米技术和质谱(MS),以推进其临床和 心脏代谢疾病的病因学、预防、诊断和治疗的转化研究。的 MDDC将开发和调整基于纳米技术的综合战略和其他创新技术, 鉴定用于早期疾病检测、预后评估和实时监测的新型生物标志物, 治疗反应以及了解心脏代谢疾病的分子机制。MDDC 旨在促进跨越分析化学-生物学界面的研究,使研究人员能够 确定和解决临床和转化科学中重要的跨学科研究问题, 心脏代谢疾病根据我们团队的专业知识,MDDC将为COBRE调查人员提供 最先进的分析技术,如MS和基于微阵列的蛋白质组学的培训和服务 和芯片上器官等,用于分析组织和生物流体样品的复杂蛋白质组。的 MDDC还将确定适当的现有分析方法,并采用新开发的方法, 没有成熟的技术。MDDC将设在杜兰大学中心内 用于细胞和分子诊断,已在传染病和慢性疾病方面建立了良好的基础 research.在COBRE第二阶段,MDDC将提供尖端的工具和方法, 支持项目2和项目3的研究授权书开展各自的研究项目。此外,MDDC将 为项目1和4的RPL提供专家咨询和最先进的技术,以开发R 01 应用于进一步研究APOL 1对慢性肾脏疾病进展的分子机制, 钾摄入量对降低血压的作用。拟议的MDDC将加强互动, COBRE,非COBRE和参与分子研究的外部研究者之间的合作 心脏代谢疾病由于MDDC是COBRE计划的关键组成部分,我们的长期目标是 将MDDC发展成为一个可持续的资源,服务于从基础科学到转化研究的所有阶段, 从临床科学到人口科学,提供广泛的最先进的细胞 分子分析服务。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tony Y. Hu其他文献

IP-MS Analysis of ESX-5 and ESX-1 Substrates Enables Mycobacterial Species Identification
ESX-5 和 ESX-1 底物的 IP-MS 分析可实现分枝杆菌菌种鉴定
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Qingbo Shu;Meena U Rajagopal;Jia Fan;Lingpeng Zhan;Xiangxing Kong;Yifan He;Suwatchareeporn Rotcheewaphan;Christopher J. Lyon;W. Sha;A. Zelazny;Tony Y. Hu
  • 通讯作者:
    Tony Y. Hu
Phenotypic plasticity and secretory heterogeneity in subpopulations derived from single cancer cell
源自单个癌细胞的亚群中的表型可塑性和分泌异质性
  • DOI:
    10.1016/j.apsb.2025.02.039
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    14.600
  • 作者:
    Zhun Lin;Siping Liang;Zhe Pu;Zhengyu Zou;Luxuan He;Christopher J. Lyon;Yuanqing Zhang;Tony Y. Hu;Minhao Wu
  • 通讯作者:
    Minhao Wu
Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples
  • DOI:
    10.1016/j.gastha.2024.08.002
  • 发表时间:
    2024-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Warapen Treekitkarnmongkol;Jianliang Dai;Suyu Liu;Deivendran Sankaran;Tristian Nguyen;Seetharaman Balasenthil;Mark W. Hurd;Meng Chen;Hiroshi Katayama;Sinchita Roy-Chowdhuri;George A. Calin;Randall E. Brand;Paul D. Lampe;Tony Y. Hu;Anirban Maitra;Eugene J. Koay;Ann M. Killary;Subrata Sen
  • 通讯作者:
    Subrata Sen
Recent advances in the bench-to-bedside translation of cancer nanomedicines
癌症纳米医学从实验室到临床转化的最新进展
  • DOI:
    10.1016/j.apsb.2024.12.007
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    14.600
  • 作者:
    Yang Liu;Yinchao Zhang;Huikai Li;Tony Y. Hu
  • 通讯作者:
    Tony Y. Hu
Decoding the blood peptidome as a new biomarker resource for cancer detection
解码血液肽组作为癌症检测的新生物标志物资源
  • DOI:
    10.15406/mojpb.2016.03.00099
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yaojun Li;Tony Y. Hu
  • 通讯作者:
    Tony Y. Hu

Tony Y. Hu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tony Y. Hu', 18)}}的其他基金

Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood
血液中无细胞结核分枝杆菌 DNA 及其耐药变异体的多重检测
  • 批准号:
    10639855
  • 财政年份:
    2023
  • 资助金额:
    $ 17.38万
  • 项目类别:
Quantification of brain-derived extracellular vesicle microRNAs in blood by a liposome-mediated CRISPR assay for traumatic brain injury detection
通过脂质体介导的 CRISPR 测定对血液中脑源性细胞外囊泡 microRNA 进行定量,用于检测创伤性脑损伤
  • 批准号:
    10575436
  • 财政年份:
    2022
  • 资助金额:
    $ 17.38万
  • 项目类别:
A nanopore biosensor for leveling Mtb antigens in blood
用于平衡血液中 Mtb 抗原的纳米孔生物传感器
  • 批准号:
    10646134
  • 财政年份:
    2022
  • 资助金额:
    $ 17.38万
  • 项目类别:
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples
血浆微样品中肿瘤源性细胞外囊泡的数字纳米等离子体定量
  • 批准号:
    10684737
  • 财政年份:
    2020
  • 资助金额:
    $ 17.38万
  • 项目类别:
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples
血浆微样品中肿瘤源性细胞外囊泡的数字纳米等离子体定量
  • 批准号:
    10461970
  • 财政年份:
    2020
  • 资助金额:
    $ 17.38万
  • 项目类别:
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples
血浆微样品中肿瘤源性细胞外囊泡的数字纳米等离子体定量
  • 批准号:
    10269902
  • 财政年份:
    2020
  • 资助金额:
    $ 17.38万
  • 项目类别:
Detecting pathogen and host factors on extracellular vesicles for pediatric TB diagnosis and management
检测细胞外囊泡上的病原体和宿主因子,用于儿童结核病的诊断和管理
  • 批准号:
    10753281
  • 财政年份:
    2017
  • 资助金额:
    $ 17.38万
  • 项目类别:
Multiplexed quantification of circulating peptidomic signatures for EBOLA early diagnosis
用于埃博拉早期诊断的循环肽组特征的多重定量
  • 批准号:
    9387209
  • 财政年份:
    2017
  • 资助金额:
    $ 17.38万
  • 项目类别:
Direct quantitation of the circulating Mtb-peptidome for pediatric TB management
直接定量循环 Mtb 肽组用于儿科结核病管理
  • 批准号:
    9333558
  • 财政年份:
    2017
  • 资助金额:
    $ 17.38万
  • 项目类别:
Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Monitoring
用于儿童结核病诊断和治疗监测的循环抗原定量
  • 批准号:
    9241942
  • 财政年份:
    2016
  • 资助金额:
    $ 17.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了